Ohio House approves abortion ban after heartbeat
Tue,28 Jun 2011 04:56 PM PDT
Reuters - COLUMBUS (Reuters) - The Ohio House of Representatives on Tuesday voted to ban abortions after a fetal heartbeat is detectable, which can be as early as six weeks. Full Story1
Tue,28 Jun 2011 04:56 PM PDT
Reuters - COLUMBUS (Reuters) - The Ohio House of Representatives on Tuesday voted to ban abortions after a fetal heartbeat is detectable, which can be as early as six weeks. Full Story1
Surgeons in Medtronic trials omitted results: report Tue,28 Jun 2011 04:26 PM PDT Reuters - NEW YORK (Reuters) - Surgeons conducting clinical trials to test a Medtronic Incbone-growth protein used in spine surgery, some of whom got at least $62 million from the company, failed to report serious complications in their research papers, the Wall Street Journal reported. Full Story1 |
Aspirin might interfere with new heart drug Tue,28 Jun 2011 02:22 PM PDT Reuters - LONDON (Reuters) - A new study backs up a suggestion that high dosages of aspirin may interfere with AstraZeneca's heart drug Brilinta, offering a possible explanation for disappointing results from a study of patients in North America. Full Story1 |
Kids who survive cancer more often get new tumors Tue,28 Jun 2011 02:21 PM PDT Reuters - NEW YORK (Reuters Health) - Children who have beaten cancer once are at increased risk of developing new tumors down the road, researchers say. Full Story1 |
Can the Internet help you lose weight? Tue,28 Jun 2011 02:20 PM PDT Reuters - NEW YORK (Reuters Health) - People tend to lose a little more weight with online help than with traditional weight loss programs, according to a new study from Japan. Full Story1 |
 SILVER SPRING, Maryland (Reuters) - Breast cancer patients testified that Roche Holding AG's Avastin saved their lives as U.S. health officials weighed whether the world's best-selling cancer drug should remain approved for that condition. |
Death rates higher for patients in U.S. territories Tue,28 Jun 2011 12:30 PM PDT Reuters - NEW YORK (Reuters Health) - Hospitals in the U.S. territories see more deaths after heart attacks, heart failure and pneumonia than the states, according to a study out Tuesday. Full Story1 |
Germany shuts school over E.coli scare Tue,28 Jun 2011 11:47 AM PDT Reuters - BERLIN (Reuters) - German officials closed a primary school in the west of the country on Tuesday after a number of students fell ill with the rare strain of E.coli responsible for an outbreak that has killed 48 people. Full Story1 |
Programs may curb hepatitis C in drug users Tue,28 Jun 2011 11:30 AM PDT Reuters - NEW YORK (Reuters Health) - Programs that give injection drug users clean needles or safer drug substitutes may help cut their odds of contracting the liver infectionhepatitis C, a new study suggests. Full Story1 |
Malaria funding rise fills drug pipeline Tue,28 Jun 2011 10:26 AM PDT Reuters - LONDON (Reuters) - Annual funding for research and development (R&D) in the fight against malaria has quadrupled over 16 years, generating the strongest pipeline of potential treatments in history, according to a report on Tuesday. Full Story1 |
Metformin, diet cost-effective to avert diabetes Tue,28 Jun 2011 09:53 AM PDT Reuters - SAN DIEGO (Reuters) - Generic drug metformin is a cost-effective way to help prevent Type 2 diabetes in people at high risk of developing the chronic condition, according to a new economic analysis. Full Story1 |
Pediatrician group urges ban on junk food ads Mon,27 Jun 2011 03:04 PM PDT Reuters - LOS ANGELES/NEW YORK (Reuters) - U.S. pediatricians want to ban junk food ads aimed at children, saying that they conspire with sedentary activities like watching television and playing video games to make kids fat. Full Story1 |
Neurontin study more marketing than science: report Mon,27 Jun 2011 02:33 PM PDT Reuters - NEW YORK (Reuters Health) - A study of the safety and effectiveness of an anti-epilepsy drug mislead doctors and patients about the point of the research, suggests a new report. Full Story1 |
Neurontin study more marketing than science: report Mon,27 Jun 2011 02:33 PM PDT Reuters - NEW YORK (Reuters Health) - A study of the safety and effectiveness of an anti-epilepsy drug mislead doctors and patients about the point of the research, suggests a new report. Full Story1 |
Can vitamin D lower your risk of melanoma? Mon,27 Jun 2011 02:32 PM PDT Reuters - NEW YORK (Reuters Health) - Taking vitamin D may help protect women who have already had non-melanoma skin cancers against a much deadlier form of the disease, suggests a new study. Full Story1 |
email: info@als-alexander.org or interalex2@gmail.com
No comments:
Post a Comment